F-Prime
Portfolio companies
F-Prime is on record against 32 companies.
1Money
1upHealth
3F Labs
Abelian Therapeutics
ABK Biomedical, Inc.
Acacia Pharma
Accuri Cytometers
Aclaris Therapeutics
Adagene
Adaptimmune
Adcentrx Therapeutics
Adela
Aera Therapeutics
Affinia Therapeutics
Airespace
Albert Invent
Alder
Alfred
Alibaba
Alluvial
Beam Therapeutics
Benchling
Denali Therapeutics
Devoted Health
Equip
Flywire
Innovent Biologics
Iora Health
Lighthouse
PatientPing
Semma Therapeutics
Toast
Investment focus
F-Prime Capital invests across all stages globally, with a particular focus on the US market. The firm targets high-growth potential in sectors producing unicorns and revenue-leading thoroughbreds, evidenced by its portfolio of 47 unicorns and 54 companies exceeding $100M in revenue.
Related investors
- F-Prime Capital (fka Fidelity Biosciences)Also backs Denali Therapeutics and ABK Biomedical, Inc. and 30 more of the same companies
- Eight Roads VenturesAlso backs Alibaba and Adaptimmune and 1 more of the same companies
- Google VenturesAlso backs Aera Therapeutics and Affinia Therapeutics
- Rock Health CapitalAlso backs Benchling and Equip
- Alaya CapitalAlso backs Equip
Public profile · MentionFox — investor research, warm-intro mapping, and full reports.